Atopic Dermatitis

In a recent study, researchers investigated the effects of adjuvant therapy with vitamin D supplementation in patients with moderate to severe disease severity.

The US Food and Drug Administration has approved Dupixent for the treatment of moderate-to-severe eczema in adults.

The US Food and Drug Administration has approved Dupixent for the treatment of moderate-to-severe eczema in adults.

Researchers sought to determine the effectiveness of oral and topical antibiotics and corticosteroids in treating clinically infected eczema in children.

Researchers sought to determine the effectiveness of oral and topical antibiotics and corticosteroids in treating clinically infected eczema in children.

The FDA has approved a new ointment for the treatment of mild-to-moderate eczema in patients aged 2 years and older.

The FDA has approved a new ointment for the treatment of mild-to-moderate eczema in patients aged 2 years and older.

By Reuters Staff

By Reuters Staff

The FDA has approved Eucrisa (crisaborole) ointment for the treatment of mild to moderate eczema (atopic dermatitis) in patients aged 2 years and older.